Catecholaminergic Polymorphic Ventricular Tachycardia clinical trials

Explore recruiting catecholaminergic polymorphic ventricular tachycardia clinical trials.

Recruiting catecholaminergic polymorphic ventricular tachycardia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Catecholaminergic Polymorphic Ventricular Tachycardia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A PHASE 2A, INVESTIGATOR AND SUBJECT BLINDED, SPONSOR UNBLINDED, PLACEBO-CONTROLLED, CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF CRD-4730 IN PARTICIPANTS WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA

France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A PHASE 2, DOUBLE-BLIND, REPEAT-DOSE, PLACEBO-CONTROLLED CROSSOVER STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF CRD-4730 IN PARTICIPANTS WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA

Netherlands, Spain, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2a Trial to Investigate Safety, Tolerability and Exploratory Clinical Efficacy of AGP100 in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Catecholaminergic Polymorphic Ventricular Tachycardia trials by city

Catecholaminergic Polymorphic Ventricular Tachycardia in Toronto Catecholaminergic Polymorphic Ventricular Tachycardia in Vancouver Catecholaminergic Polymorphic Ventricular Tachycardia in Montreal Catecholaminergic Polymorphic Ventricular Tachycardia in Calgary Catecholaminergic Polymorphic Ventricular Tachycardia in Edmonton Catecholaminergic Polymorphic Ventricular Tachycardia in Ottawa Catecholaminergic Polymorphic Ventricular Tachycardia in Winnipeg Catecholaminergic Polymorphic Ventricular Tachycardia in Quebec City Catecholaminergic Polymorphic Ventricular Tachycardia in Hamilton Catecholaminergic Polymorphic Ventricular Tachycardia in Kitchener Catecholaminergic Polymorphic Ventricular Tachycardia in London Catecholaminergic Polymorphic Ventricular Tachycardia in Halifax Catecholaminergic Polymorphic Ventricular Tachycardia in New York Catecholaminergic Polymorphic Ventricular Tachycardia in Los Angeles Catecholaminergic Polymorphic Ventricular Tachycardia in Chicago Catecholaminergic Polymorphic Ventricular Tachycardia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease